BEC (Common Stock)
Exchange NYSE
Price64.58
Change- 0.82
% Change- 1.25%
Volume441,867
11/20/09 4:00 p.m. ET
Minimum 20 mins. delay
More 
 
 
 

 Press Release

Printer FriendlyPrinter Friendly Version 
Beckman Coulter Pending Acquisition of Olympus Diagnostics Systems Passes Milestone with U.S. Regulatory Approval

ORANGE COUNTY, Calif., May 13 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, today announced that the Federal Trade Commission has terminated its review under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended, of the company's pending acquisition of Olympus Corporation's lab-based diagnostics business.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

As previously announced on February 27, 2009, Beckman Coulter and Olympus announced that they had entered into a definitive agreement under which Beckman Coulter will acquire the diagnostic systems portion of Olympus' Life Sciences business for approximately USD $780 million.

This transaction is expected to close in the third quarter of 2009 and is subject to certain government approvals outside the United States, the negotiation of certain ancillary agreements, the delivery of and agreement to disclosure schedules and transition arrangements as well as other customary conditions.

About Beckman Coulter

Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies, (including reagent test kits), service and operating-type lease payments, represent about 78% of the company's 2008 revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.

Contacts: Investor Relations
Cynthia Skoglund
(714) 773-7620

Media Relations
Mary Luthy
(714) 773-7964

SOURCE Beckman Coulter, Inc.
05/13/2009
CONTACT: Investor Relations, Cynthia Skoglund, +1-714-773-7620, or Media Relations, Mary Luthy, +1-714-773-7964, both for Beckman Coulter, Inc.

Photo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO
http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web Site: http://www.beckmancoulter.com

 Back to Press Releases

 

 

 
 
Home | Products | Customer Support | Resource Center
Employment | Our Company | Contact Us | Site Map
 Privacy©1998 - 2007 Beckman Coulter, Inc.
Printing Instructions